GE HealthCare Q3 revenue up 6% to $5.1B; adjusted EPS down to $1.07 from $1.14; raises low end of FY guidance

GE HealthCare Technologies Inc.

2025-Q3 EPS reported $3.26 vs consensus $1.07 ▲ beat (+204.2%)

Revenue $5.1B (+6% reported, +4% organic); organic orders +6% across all segments.
Net income $446M ($0.98 diluted EPS) vs $470M ($1.02); adjusted EPS $1.07 vs $1.14.
Segment EBIT margin declines: Imaging 10.2% (-260bps), Patient Care Solutions 3.7% (-680bps), Pharmaceutical Diagnostics 29.4% (-150bps).
Full-year adjusted EPS guidance low end raised to $4.51-$4.63 (prev $4.43-$4.63); organic revenue ~3% growth reaffirmed.
Management cites ~$265M tariff impact on adjusted EBIT and $0.45 on adjusted EPS; free cash flow $483M vs $651M prior year.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.